
409. A New Year and New Opportunities: What's Next for the Food Movement
Food Talk with Dani Nierenberg (by Food Tank)
00:00
Exploring the Benefits and Concerns of Ozampic and GLP1 Agonists
The speakers delve into the positive effects of the GLP1 agonist drug, ozampic, on reducing blood sugar spikes, food intake, appetite, and hunger for individuals with diabetes and obesity. They also discuss concerns about the high cost, limited insurance coverage, potential health implications, and the impact on body positivity.
Transcript
Play full episode